BioCentury

12:49 AM GMT, Apr 8, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Epix announces MS-325 deal, exchange offer

Epix Pharmaceuticals Inc. (NASDAQ:EPIX) sold U.S., Canadian and Australian rights to MS-325 (formerly Vasovist

Read the full 147 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.